163 related articles for article (PubMed ID: 38580878)
1. Prognostic utility and characteristics of MIB-1 labeling index as a proliferative activity marker in childhood low-grade glioma: a retrospective observational study.
Gorodezki D; Zipfel J; Bevot A; Nägele T; Ebinger M; Schuhmann MU; Schittenhelm J
J Cancer Res Clin Oncol; 2024 Apr; 150(4):178. PubMed ID: 38580878
[TBL] [Abstract][Full Text] [Related]
2. Resection extent and BRAF V600E mutation status determine postoperative tumor growth velocity in pediatric low-grade glioma: results from a single-center cohort analysis.
Gorodezki D; Zipfel J; Queudeville M; Sosa J; Holzer U; Kern J; Bevot A; Schittenhelm J; Nägele T; Ebinger M; Schuhmann MU
J Neurooncol; 2022 Dec; 160(3):567-576. PubMed ID: 36319795
[TBL] [Abstract][Full Text] [Related]
3. Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort.
Pollack IF; Hamilton RL; Burnham J; Holmes EJ; Finkelstein SD; Sposto R; Yates AJ; Boyett JM; Finlay JL
Neurosurgery; 2002 Jun; 50(6):1238-44; discussion 1244-5. PubMed ID: 12015841
[TBL] [Abstract][Full Text] [Related]
4. Low expression of Ki-67/MIB-1 labeling index in IDH wild type glioblastoma predicts prolonged survival independently by MGMT methylation status.
Tini P; Yavoroska M; Mazzei MA; Miracco C; Pirtoli L; Tomaciello M; Marampon F; Minniti G
J Neurooncol; 2023 Jun; 163(2):339-344. PubMed ID: 37227648
[TBL] [Abstract][Full Text] [Related]
5. Value of MIB-1 labelling index (LI) in gliomas and its correlation with other prognostic factors. A clinicopathologic study.
Rodríguez-Pereira C; Suárez-Peñaranda JM; Vázquez-Salvado M; Sobrido MJ; Abraldes M; Barros F; Forteza J
J Neurosurg Sci; 2000 Dec; 44(4):203-9; discussion 209-10. PubMed ID: 11327289
[TBL] [Abstract][Full Text] [Related]
6. Study of the MIB-1 labeling index as a predictor of tumor progression in pilocytic astrocytomas in children and adolescents.
Bowers DC; Gargan L; Kapur P; Reisch JS; Mulne AF; Shapiro KN; Elterman RD; Winick NJ; Margraf LR
J Clin Oncol; 2003 Aug; 21(15):2968-73. PubMed ID: 12885817
[TBL] [Abstract][Full Text] [Related]
7. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
[TBL] [Abstract][Full Text] [Related]
8. Interobserver variability associated with the MIB-1 labeling index: high levels suggest limited prognostic usefulness for patients with primary brain tumors.
Grzybicki DM; Liu Y; Moore SA; Brown HG; Silverman JF; D'Amico F; Raab SS
Cancer; 2001 Nov; 92(10):2720-6. PubMed ID: 11745208
[TBL] [Abstract][Full Text] [Related]
9. An initial study on the predictive value using multiple MRI characteristics for Ki-67 labeling index in glioma.
Du N; Shu W; Li K; Deng Y; Xu X; Ye Y; Tang F; Mao R; Lin G; Li S; Fang X
J Transl Med; 2023 Feb; 21(1):119. PubMed ID: 36774480
[TBL] [Abstract][Full Text] [Related]
10. Analysis of proliferation and apoptosis in brain gliomas: prognostic and clinical value.
Heesters MA; Koudstaal J; Go KG; Molenaar WM
J Neurooncol; 1999; 44(3):255-66. PubMed ID: 10720205
[TBL] [Abstract][Full Text] [Related]
11. Proliferation index as a predictor of prognosis in malignant gliomas of childhood.
Pollack IF; Campbell JW; Hamilton RL; Martinez AJ; Bozik ME
Cancer; 1997 Feb; 79(4):849-56. PubMed ID: 9024724
[TBL] [Abstract][Full Text] [Related]
12. Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas.
Onda K; Davis RL; Shibuya M; Wilson CB; Hoshino T
Cancer; 1994 Oct; 74(7):1921-6. PubMed ID: 7521787
[TBL] [Abstract][Full Text] [Related]
13. The proliferative potential of the pilocytic astrocytoma: the relation between MIB-1 labeling and clinical and neuro-radiological follow-up.
Dirven CM; Koudstaal J; Mooij JJ; Molenaar WM
J Neurooncol; 1998 Mar; 37(1):9-16. PubMed ID: 9525833
[TBL] [Abstract][Full Text] [Related]
14. The prognostic significance of Ki-67 labeling indices for oligodendrogliomas.
Coons SW; Johnson PC; Pearl DK
Neurosurgery; 1997 Oct; 41(4):878-84; discussion 884-5. PubMed ID: 9316050
[TBL] [Abstract][Full Text] [Related]
15. Proliferative activity as measured by MIB-1 labeling index and long-term outcome of cerebellar juvenile pilocytic astrocytomas.
Roessler K; Bertalanffy A; Jezan H; Ba-Ssalamah A; Slavc I; Czech T; Budka H
J Neurooncol; 2002 Jun; 58(2):141-6. PubMed ID: 12164686
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological features, MIB-1 labeling index and apoptotic index in recurrent astrocytic tumors.
Ralte AM; Sharma MC; Karak AK; Mehta VS; Sarkar C
Pathol Oncol Res; 2001; 7(4):267-78. PubMed ID: 11882906
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the safety of perioperative dexamethasone treatment: A retrospective analysis of a single center pediatric low-grade glioma cohort.
Gorodezki D; Zipfel J; Queudeville M; Holzer U; Bevot A; Schittenhelm J; Nägele T; Schuhmann MU; Ebinger M
Int J Cancer; 2023 May; 152(9):1875-1883. PubMed ID: 36522830
[TBL] [Abstract][Full Text] [Related]
18. The clinical value of Ki-67/MIB-1 labeling index in human astrocytomas.
Johannessen AL; Torp SH
Pathol Oncol Res; 2006; 12(3):143-7. PubMed ID: 16998593
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical assessment of the MIB-1 Labeling Index in human hepatoblastoma and its prognostic relevance.
Ara T; Fukuzawa M; Oue T; Komoto Y; Kusafuka T; Imura K; Okada A
J Pediatr Surg; 1997 Dec; 32(12):1690-4. PubMed ID: 9434000
[TBL] [Abstract][Full Text] [Related]
20. Relationship between Ki-67 labeling index and survival in high-grade glioma patients treated after surgery with tamoxifen.
Mastronardi L; Guiducci A; Puzzilli F; Ruggeri A
J Neurosurg Sci; 1999 Dec; 43(4):263-70. PubMed ID: 10864388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
